IS4438A - Lyfjaþrýstiúðasamsetningar og aðferð til framleiðslu þeirra - Google Patents

Lyfjaþrýstiúðasamsetningar og aðferð til framleiðslu þeirra

Info

Publication number
IS4438A
IS4438A IS4438A IS4438A IS4438A IS 4438 A IS4438 A IS 4438A IS 4438 A IS4438 A IS 4438A IS 4438 A IS4438 A IS 4438A IS 4438 A IS4438 A IS 4438A
Authority
IS
Iceland
Prior art keywords
manufacture
aerosol formulations
pressure aerosol
pharmaceutical pressure
pharmaceutical
Prior art date
Application number
IS4438A
Other languages
English (en)
Other versions
IS1991B (is
Inventor
Li-Bovet Li
Arthur Johnson Keith
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of IS4438A publication Critical patent/IS4438A/is
Publication of IS1991B publication Critical patent/IS1991B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
IS4438A 1994-09-28 1997-03-10 Lyfjaþrýstiúðasamsetningar og aðferð til framleiðslu þeirra IS1991B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
IS4438A true IS4438A (is) 1997-03-10
IS1991B IS1991B (is) 2005-02-15

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4438A IS1991B (is) 1994-09-28 1997-03-10 Lyfjaþrýstiúðasamsetningar og aðferð til framleiðslu þeirra

Country Status (32)

Country Link
US (1) US5849265A (is)
EP (1) EP0783302B1 (is)
JP (1) JPH10506887A (is)
KR (1) KR100375469B1 (is)
CN (1) CN1084614C (is)
AP (1) AP742A (is)
AT (1) ATE187063T1 (is)
AU (1) AU707922B2 (is)
BG (1) BG62839B1 (is)
BR (1) BR9509108A (is)
CZ (1) CZ286356B6 (is)
DE (1) DE69513671T2 (is)
DK (1) DK0783302T3 (is)
EE (1) EE03380B1 (is)
ES (1) ES2140706T3 (is)
FI (1) FI971279L (is)
GB (1) GB9419536D0 (is)
GE (1) GEP20002140B (is)
GR (1) GR3032245T3 (is)
HU (1) HU221856B1 (is)
IS (1) IS1991B (is)
MD (1) MD1900C2 (is)
MX (1) MX9702149A (is)
NO (1) NO313658B1 (is)
NZ (1) NZ292995A (is)
OA (1) OA10603A (is)
PL (1) PL181453B1 (is)
RO (1) RO118564B1 (is)
RU (1) RU2157188C2 (is)
SK (1) SK281519B6 (is)
UA (1) UA47412C2 (is)
WO (1) WO1996009816A1 (is)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
DK1169019T3 (da) * 1999-04-14 2003-06-02 Glaxo Group Ltd Farmaceutisk aerosolformulering
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
SI1775305T1 (sl) * 2000-08-05 2015-01-30 Glaxo Group Limited S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
US7217409B2 (en) 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
KR100831534B1 (ko) * 2001-04-30 2008-05-22 글락소 그룹 리미티드 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체
ES2307751T3 (es) * 2001-06-12 2008-12-01 Glaxo Group Limited Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
ES2293157T3 (es) * 2001-08-03 2008-03-16 Glaxo Group Limited Compuestos tensioactivos y uso de los mismos.
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
CA2474626A1 (en) * 2002-02-13 2003-08-21 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
AU2004264941B2 (en) 2003-08-11 2008-11-27 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
EP1658105B1 (en) 2003-08-29 2018-03-14 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
DE602005009012D1 (de) * 2004-10-12 2008-09-25 Generics Uk Ltd Rmulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5529524A (en) * 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US4965066A (en) * 1989-06-06 1990-10-23 E. I. Du Pont De Nemours And Company Intranasal administration of 3,3-disubstituted indolines
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) * 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
AU650463B2 (en) * 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
BR9509108A (pt) 1998-07-14
SK281519B6 (sk) 2001-04-09
OA10603A (en) 2002-08-30
EE03380B1 (et) 2001-04-16
EE9700061A (et) 1997-08-15
RU2157188C2 (ru) 2000-10-10
MD1900C2 (ro) 2002-12-31
MX9702149A (es) 1998-04-30
KR970705981A (ko) 1997-11-03
US5849265A (en) 1998-12-15
FI971279A7 (fi) 1997-03-26
CZ93697A3 (en) 1997-08-13
PL181453B1 (pl) 2001-07-31
WO1996009816A1 (en) 1996-04-04
FI971279A0 (fi) 1997-03-26
FI971279L (fi) 1997-03-26
BG62839B1 (bg) 2000-09-29
BG101347A (en) 1997-12-30
EP0783302A1 (en) 1997-07-16
MD1900B2 (en) 2002-04-30
NO971422L (no) 1997-05-23
GEP20002140B (en) 2000-06-25
AP742A (en) 1999-04-26
GR3032245T3 (en) 2000-04-27
AP9700951A0 (en) 1997-04-30
IS1991B (is) 2005-02-15
EP0783302B1 (en) 1999-12-01
PL319342A1 (en) 1997-08-04
CN1168630A (zh) 1997-12-24
DE69513671T2 (de) 2000-04-06
DK0783302T3 (da) 2000-05-29
MD970134A (en) 1999-02-28
GB9419536D0 (en) 1994-11-16
HUT77377A (hu) 1998-04-28
UA47412C2 (uk) 2002-07-15
SK39397A3 (en) 1997-10-08
AU707922B2 (en) 1999-07-22
NO971422D0 (no) 1997-03-25
RO118564B1 (ro) 2003-07-30
DE69513671D1 (de) 2000-01-05
NZ292995A (en) 1998-10-28
ATE187063T1 (de) 1999-12-15
AU3532195A (en) 1996-04-19
CZ286356B6 (cs) 2000-03-15
KR100375469B1 (ko) 2003-10-17
JPH10506887A (ja) 1998-07-07
HU221856B1 (hu) 2003-02-28
ES2140706T3 (es) 2000-03-01
CN1084614C (zh) 2002-05-15
NO313658B1 (no) 2002-11-11

Similar Documents

Publication Publication Date Title
IS1991B (is) Lyfjaþrýstiúðasamsetningar og aðferð til framleiðslu þeirra
NO972781D0 (no) Aerosolformuleringer av peptider og proteiner
DK0445382T3 (da) Trykføler og fremgangsmåde til fremstilling heraf
DK0832565T3 (da) Mælkeerstatningsprodukt og fremgangsmåde til fremstilling deraf
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
ATE236617T1 (de) Aerosol-arzneiformulierungen
NO20010260D0 (no) Tarmbeskyttelsesbelagt farmasöytisk tablett og fremgangsmåte for fremstilling
IS6197A (is) Aðferð og búnaður til að koma lyfjablöndum á úðaform
NO985720L (no) Aerosol legemiddelformuleringer av formoterol
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
IS1622B (is) Úðamyndunaraðferð og -búnaður til inntöku lyfja með innöndun
NO931326D0 (no) Komposittprodukt og fremgangsmaate til fremstilling derav
NO20006466D0 (no) Oppmålt doseinhalator under trykk og farmasöytiske aerosolformuleringer
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
NO971650D0 (no) Renibacterium salmoninarum vaksine og fremgangsmåte til fremstilling derav
DK0596122T3 (da) Fremgangsmåde til omvikling og omviklet genstand
FI961521L (fi) Lääkeformulaatioiden valmistusmenetelmä
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
IS4779A (is) Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu
NO975634D0 (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
DE69629359D1 (de) Trimebutinhaltiges arzneimittel und verfahren
IS4035A (is) Benzodiazepinesefni, aðferð til framleiðslu þeirra og notkunar sem lyfja